NR AGWN
AU Kulikov,V.V.; Derkatch,I.L.; Noskov,V.N.; Tarunina,O.V.; Chernoff,Y.O.; Rogozin,I.B.; Pavlov,Y.I.
TI Mutagenic specificity of the base analog 6-N-hydroxylaminopurine in the LYS2 gene of yeast Saccharomyces cerevisiae
QU Mutation Research 2001 Feb 20; 473(2): 151-61
PT journal article
AB We used the LYS2 gene mutational system to study mutation specificity of the base analog 6-N-hydroxylaminopurine (HAP) in yeast. We characterized phenotypes of mutations using codon-specific nonsense suppressors and the test employing inactivation of the release factor Sup35 due to overexpression and formation of prion-like derivative [PSI]. We have shown that HAP induces predominantly nonsense mutations. While the tests using codon-specific nonsense-suppressors allowed to identify only about 50% of nonsense-mutations, all the nonsense-mutations were identified in the test with defective Sup35. We determined and analyzed the spectrum of HAP-induced nucleotide changes in two regions of the gene. HAP induces predominantly GC -> AT transitions in a hotspots of a central position of trinucleotide GGA or AGG. Directionality of these transitions is consistent with the idea that initial dHAPMP incorporation in the leading strand is more genetically dangerous than in lagging DNA strand. We revealed a specific context inhibitory for HAP mutagenesis, a "T" in -1 position to mutation site.
MH Adenine/*analogs & derivatives/*pharmacology; Aldehyde Oxidoreductases/*genetics; Antisense Elements (Genetics); Codon, Nonsense; DNA Mutational Analysis; Mutagenesis; Mutagens/*pharmacology; Phenotype; Saccharomyces cerevisiae/*genetics; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Suppression, Genetic
AD Department of Genetics, Sankt-Petersburg State University, Sankt-Petersburg 199034, Russia.
SP englisch
PO Niederlande